Clinical Trial Update: Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

The Phase 4 study evaluating symptomatic relief with FLOMAX (tamsulosin) in benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Flomax (tamsulosin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED